20080701 FDA advisory committee: endocrinologic, metabolic

http://www.fda.gov/ohrms/dockets/ac/cder08.html#EndocrinologicMetabolic

7月1,2日に開かれたadvisory committeeの資料
新規糖尿病薬について長期試験でCV安全性確認を必要と勧告

Endocrinologic and Metabolic Drugs Advisory CommitteeExecutive Secretary: Cathy A. Miller, MPH, RN, (HFD-21), (301) 827-7001
July 1 and 2, 2008
Notice of Meeting [TXT] [PDF] [PRE-PUB]
Waivers for Conflicts of Interest for July 1 and 2, 2008 Meeting (htm)
Agenda for July 1 and 2, 2008 Meeting (pdf)
Rosters for July 1 and 2, 2008 Meeting: Committee (pdf), Meeting (pdf)
Questions for July 1 and 2, 2008 Meeting (pdf)
Briefing Information for July 1 and 2, 2008 Meeting (htm)